Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin | Patent Number 08853231
US 08853231 B2Filled DateNov 16, 2012
Priority DateNov 4, 2004
Publication DateOct 31, 2013
Expiration DateNov 4, 2024
Inventor/ApplicantsGiuseppe Claudio Viscomi
Paolo Righi
Goffredo Rosini
Dario Braga
Donatella Confortini
Manuela Campana
Vincenzo Cannata
Paolo Righi
Goffredo Rosini
Dario Braga
Donatella Confortini
Manuela Campana
Vincenzo Cannata
ExaminesKIFLE, BRUCK
Art Unit1622
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.